Controlling signs and symptoms due to myocardial ischemia
Both
Neither
Anti-thrombogenic effects of aspirin involve which one(s) of the following?
"Irreversible" cyclooxygenase-1 inhibition
Inhibition of platelet thromboxane A2
Both
Neither
In an angina clinical trial (Swedish) the protective effects relative to myocardial infarction, sudden death, and vascular events relative to placebo was estimated to be approximately:
10% Reduction
33% Reduction
45% reduction
55% reduction
Daily use of aspirin in the range of 75-162 mg/day given for secondary prevention of myocardial infarction in men than women who have chronic ischemic heart disease is an AHA class I recommendation.
True
False
Choose the correct statement(s) concerning the pharmacology of clopidogrel.
Clopidogrel acts primarily on endothelial cells, preventing proliferation.
Clopidogrel should never be used in combination with aspirin due to unacceptably high bleeding risk
All of the above
Clopidogrel is a "class I" recommendation for ST-segment elevation in myocardial infarction patients treated with fibrinolysis were not receiving reperfusion intervention.
True
False
Combining clopidogrel and aspirin reduces the likelihood of myocardial infarction, stroke or death due to cardiovascular events.
True
False
Ticagrelor when administered for one year appeared more beneficial compared to clopidogrel using the endpoint of death from cardiovascular causes, myocardial infarction or stroke.
True
False
Ticagrelor is primarily classified as a:
Negative inotropic agent
Inhibitor platelet aggregation
Stimulant of hematopoiesis
None of the above
Ticagrelor administration tended to decrease the likelihood of dyspnea and bradyarrhythmias.